Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Humoral and cellular responses to SARS-CoV-2 vaccination in patients with lymphoid malignancies

Sean H. Lim, Nicola Campbell, Beth Stuart, Marina Johnson, Debora Joseph-Pietras, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W.M. Johnson, Andrew J. Davies, David Goldblatt
doi: https://doi.org/10.1101/2021.12.08.21266760
Sean H. Lim
1Centre for Cancer Immunology, University of Southampton, Southampton, SO16 6YD, UK
2Cancer Research UK Research Centre, University of Southampton, SO16 6YD, UK
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.h.lim@soton.ac.uk
Nicola Campbell
1Centre for Cancer Immunology, University of Southampton, Southampton, SO16 6YD, UK
2Cancer Research UK Research Centre, University of Southampton, SO16 6YD, UK
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth Stuart
4Southampton Clinical Trials Unit, University of Southampton, Southampton, SO16 YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina Johnson
5Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, WC1N 1EH, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debora Joseph-Pietras
2Cancer Research UK Research Centre, University of Southampton, SO16 6YD, UK
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Kelly
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle Jeffrey
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna H. Turaj
1Centre for Cancer Immunology, University of Southampton, Southampton, SO16 6YD, UK
2Cancer Research UK Research Centre, University of Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Rolfvondenbaumen
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celine Galloway
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Wynn
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam R. Coleman
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Ward
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Long
7University of Southampton Clinical Informatics Research Unit, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew T. Bates
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Ayres
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Lown
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janlyn Falconer
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Brake
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Batchelor
7University of Southampton Clinical Informatics Research Unit, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victoria Willimott
8Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, NR4 7UY, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Bowzyk Al-Naeeb
9Department of Oncology, Bedford Hospital, Bedford, MK42 9DJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Robinson
10Department of Haematology, County Hospital Hereford, Hereford, HR1 2BN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann O’Callaghan
11Portsmouth Hospitals NHS Trust, Portsmouth, PO6 3LY, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham P. Collins
12Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Menne
13Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE7 DN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saul N. Faust
14Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, SO16 6YD, UK
15NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher P. Fox
16Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PB, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Ahearne
17University Hospitals of Leicester NHS Trust, Leicester, LE2 7LX, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter W.M. Johnson
1Centre for Cancer Immunology, University of Southampton, Southampton, SO16 6YD, UK
2Cancer Research UK Research Centre, University of Southampton, SO16 6YD, UK
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Davies
1Centre for Cancer Immunology, University of Southampton, Southampton, SO16 6YD, UK
2Cancer Research UK Research Centre, University of Southampton, SO16 6YD, UK
3University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
6NIHR/Cancer Research UK Southampton Experimental Cancer Medicine Centre, WISH Laboratory, Southampton General Hospital, Southampton, SO16 6YD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Goldblatt
5Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, WC1N 1EH, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

SUMMARY

SARS-CoV-2 vaccination protects against COVID-19. Antibodies and antigen-specific T-cell responses against the spike domain can be used to measure vaccine immune response. Individuals with lymphoma have defects in humoral and cellular immunity that may compromise vaccine response. In this prospective observational study of 457 participants with lymphoma, 52% of participants vaccinated on treatment had undetectable anti-spike IgG antibodies compared to 9% who were not on treatment. Marked impairment was observed in those receiving anti- CD20 antibody within 12 months where 60% had undetectable antibodies compared to 11% on chemotherapy, which persisted despite three vaccine doses. Overall, 63% had positive T-cell responses irrespective of treatment. Individuals with indolent B-cell lymphoma have impaired antibody and cellular responses that were independent of treatment. The significant reduction and heterogeneity in immune responses in these individuals emphasise the urgent need for immune response monitoring and alternative prophylactic strategies to protect against COVID- 19.

Competing Interest Statement

SHL, NC, MJ, DJP, AO, AK, ARC, AHT, KL, DJ, BW, TW, ATB, KR, BS, CG, DA, JF, OB, JB, VM, ABAN, LR, TM, SF, PWMJ and DG declare no competing interests. CF receives consultancy fees from AstraZeneca and participates in an advisory board for AstraZeneca, MA receives research funding from Pfizer, GPC receives research funding from Pfizer and participates in advisory boards for AstraZeneca and Pfizer, RL reports receiving speaker fees and honoraria from Janssen and AJD reports receiving research funding and honoraria from AstraZeneca and Janssen.

Funding Statement

The PROSECO study is funded by the Blood Cancer UK Vaccine Research Collaborative, which is led by Blood Cancer UK in partnership with Myeloma UK, Anthony Nolan and the British Society for Haematology (21009), and supported by Cancer Research UK Advanced Clinician Scientist Fellowship to SHL (A27179), the Cancer Research UK/NIHR Southampton Experimental Cancer Medicine Centre (A25141), the NIHR Southampton Clinical Research Facility (Southampton Research Biorepository) and NIHR Southampton Biomedical Research Centre. DG receives support from the NIHR Great Ormond Street Biomedical Research Centre.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the UK National Health Service Health Research Authority (North West-Liverpool Central Research Ethics Committee, IRAS 294739; 233768).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵19 Senior author

  • ↵20 Lead contact

Data Availability

All data produced in the present study are available upon reasonable request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with lymphoid malignancies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with lymphoid malignancies
Sean H. Lim, Nicola Campbell, Beth Stuart, Marina Johnson, Debora Joseph-Pietras, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W.M. Johnson, Andrew J. Davies, David Goldblatt
medRxiv 2021.12.08.21266760; doi: https://doi.org/10.1101/2021.12.08.21266760
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with lymphoid malignancies
Sean H. Lim, Nicola Campbell, Beth Stuart, Marina Johnson, Debora Joseph-Pietras, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W.M. Johnson, Andrew J. Davies, David Goldblatt
medRxiv 2021.12.08.21266760; doi: https://doi.org/10.1101/2021.12.08.21266760

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)